Targeting the overexpressed mitochondrial protein VDAC1 in a mouse model of Alzheimer’s disease protects against mitochondrial dysfunction and mitigates brain pathology. The gene discussed is VDAC1; the disease is early-onset autosomal dominant Alzheimer disease.